ABOS
Acumen Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+7.07%Leverage
- Debt / equity
- 0.55x
- Net debt / equity
- -0.49x
- Debt / assets
- 0.27x
- Debt / EBITDA
- -0.31x
- Net debt / EBITDA
- 0.28x
Liquidity & coverage
- Current ratio
- 2.47x
- Quick ratio
- 2.47x
- Cash ratio
- 2.35x
- Interest coverage
- -24.41x
- EBITDA / interest
- -23.28x
- Working capital
- $68.7M
Cash & dividend
- FCF / debt
- -2.91x
- Cash flow / debt
- -2.91x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026